Back to today’s briefing

Story perspectives

Stellate Ganglion Block: Promising Outpatient PTSD Treatment

9/29/2025

29 5

Summary

Story summary

Stellate Ganglion Block (SGB) shows promise for outpatient PTSD treatment with few side effects.
RTI International study found SGB improved PTSD symptoms, depression, and anxiety after eight weeks.
PTSD affects about 3.5% of U.S. adults, with an overactive fight-or-flight response that may shrink the hippocampus.
Consult a medical professional promptly to assess SGB suitability.

1 of 1

Story summary

Stellate Ganglion Block (SGB) shows promise for outpatient PTSD treatment with few side effects.
RTI International study found SGB improved PTSD symptoms, depression, and anxiety after eight weeks.
PTSD affects about 3.5% of U.S. adults, with an overactive fight-or-flight response that may shrink the hippocampus.
Consult a medical professional promptly to assess SGB suitability.